UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response:
0.5
1. Name and Address of Reporting Person*Straubel Jeffrey B
(Last)
(First)
(Middle)
C/O TESLA MOTORS, INC.
3500 DEER CREEK ROAD
(Street)
PALO ALTO
CA
94304
(City)
(State)
(Zip)
2. Date of Event Requiring Statement
(Month/Day/Year)
06/28/2010
3. Issuer Name and Ticker or Trading Symbol
TESLA MOTORS INC
[ TSLA ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director
10% Owner
Officer (give title below)
Other (specify below)
Chief Technology Officer
5. If Amendment, Date of Original Filed
(Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr.
4)
2.
Amount of Securities Beneficially Owned (Instr.
4)
3. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
4. Nature of Indirect Beneficial Ownership (Instr.
5)
Common Stock
255,249
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr.
4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security (Instr.
4)
4. Conversion or Exercise Price of Derivative Security
5. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
6. Nature of Indirect Beneficial Ownership (Instr.
5)
Date Exercisable
Expiration Date
Title
Amount or Number of Shares
Series B Preferred Stock
(1)
(1)
Common Stock
54,054
(1)
Series C Preferred Stock
(2)
(2)
Common Stock
17,621
(2)
Right to Buy (Common Stock)(3)
05/31/2007
05/30/2013
Common Stock
10,416
$0.36
Right to Buy (Common Stock)(4)
05/31/2007
11/08/2014
Common Stock
9,334
$2.1
Right to Buy (Common Stock)(5)
06/07/2008
06/03/2015
Common Stock
33,333
$2.7
Right to Buy (Common Stock)(6)
05/13/2009
04/12/2016
Common Stock
107,916
$2.7
Right to Buy (Common Stock)(7)
09/16/2009
12/03/2016
Common Stock
117,083
$6.63
Right to Buy (Common Stock)
(8)
06/11/2017
Common Stock
116,650
$14.17
Right to Buy (Common Stock)(9)
07/03/2010
06/11/2017
Common Stock
2,450
$14.17
Explanation of Responses:
1. Each share of the Issuer's Series B preferred stock will automatically convert into .333333 of a share of common stock upon the closing the Issuer's initial public offering, and has no expiration date.
2. Each share of the Issuer's Series C preferred stock will automatically convert into .350013 of a share of common stock upon the closing the Issuer's initial public offering, and has no expiration date.
3. 1/4th of the shares subject to the option became vested and exercisable on May 31, 2007 and 1/48th of the shares subject to the option shall become vested and exercisable each month thereafter.
4. 1/48th of the shares subject to the option became vested and exercisable on May 31, 2007 and 1/48th of the shares subject to the option shall become vested and exercisable each month thereafter.
5. 1/48th of the shares subject to the option became vested and exercisable on June 7, 2008 and 1/48th of the shares subject to the option shall become vested and exercisable each month thereafter.
6. 1/48th of the shares subject to the option became vested and exercisable on May 13, 2009 and 1/48th of the shares subject to the option shall become vested and exercisable each month thereafter.
7. 1/48th of the shares subject to the option became vested and exercisable on September 16, 2009 and 1/48th of the shares subject to the option shall become vested and exercisable each month thereafter.
8. Shares subject to the option become vested and exercisable upon the Issuer's achievement of certain performance objectives set forth in the option agreement.
9. 1/48th of the shares subject to the option become vested and exercisable on July 3, 2010 and 1/48th of the shares subject to the option shall become vested and exercisable each month thereafter.
Remarks:
The anticipated effective date of Issuer's initial public offering is June 28, 2010.
/s/ Jeffrey B. Straubel
06/25/2010
** Signature of Reporting Person
Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person,
see
Instruction
(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.